Kazakhstan cancer study to reveal Real-World treatment patterns
NCT ID NCT07593196
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will review medical records of about 240 adults in Kazakhstan with HER2-positive metastatic breast cancer to see how they were treated and how well they did. Researchers will look at treatments given in routine care (except one specific drug) and track outcomes like how long the cancer stayed controlled. The goal is to understand real-world practices and patient characteristics, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
'Centre for Nuclear Medicine and Oncology' Abai Regional Health Authority Semey
Semey, 71407, Kazakhstan
-
'General Regional Hospital' of the municipal state institution 'Health Department of the Akimat of North Kazakhstan Region' Petropavlovsk
Petropavl, 150000, Kazakhstan
-
'Karaganda General Hospital No. 3' of the Karaganda Region Health Department
Karaganda, 100019, Kazakhstan
-
'Kazakh Research Institute of Oncology and Radiology (KAZNIOR)'
Almaty, 50022, Kazakhstan
-
'Multidisciplinary Medical Centre' of the Astana City Administration
Astana, 10000, Kazakhstan
-
'Regional Cancer Centre' Uralsk
Oral, Kazakhstan, 90005, Kazakhstan
-
'Regional Clinical Hospital' of the Health Department of the Turkestan Region
Shymkent, 160011, Kazakhstan
-
'Shymkent City General Hospital with Oncology Centre' under the Shymkent City Health Department
Shymkent, 160000, Kazakhstan
-
'The Zhambyl Regional Multidisciplinary Centre for Oncology and Surgery' of the Health Department of the Zhambyl Regional Administration, Taraz
Taraz, 80000, Kazakhstan
-
Almaty Cancer Centre
Almaty, 50054, Kazakhstan
-
Medical Centre of the Marat Ospanov West Kazakhstan Medical University, Aktobe
Aktobe, 30017, Kazakhstan
-
National Cancer Research Centre, Astana
Astana, 10017, Kazakhstan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug attack shrink Hard-to-Treat breast cancer?
- Can mapping tumor DNA unlock personalized breast cancer care?
- Could a personal coach at home boost energy for cancer patients?
- Can an immune booster help chemotherapy fight metastatic breast cancer?
- Can a Four-Drug cocktail tame a tough breast cancer?
- Can a new drug outsmart resistant breast cancer?